Journal of Medicinal Chemistry · 2008 · 50 citations · 20 references
Life SciencesNeurosciencePharmacologyNeurochemistryNeuropharmacologyStructure-activity RelationshipsAmino Acid NeurochemistryGlutamatergic SignalingNeurotransmissionNeurotransmitter ReceptorsNeurotransmitter SystemsSynaptic TransmissionEnantioselective SynthesisEnzymatic SynthesisGlutamate NeurotransmissionGlutamatergic NeurotransmissionLigand Binding AffinityLigand-receptor AffinityPharmacology Of Glutamate ReceptorsReceptor-ligand Binding Affinity
( S)-Glutamic acid (Glu) is the major excitatory neurotransmitter in the central nervous system (CNS) activating the plethora of ionotropic Glu receptors (iGluRs) and metabotropic Glu receptors (mGluRs). In this paper, we present a chemo-enzymatic strategy for the enantioselective synthesis of five new Glu analogues 2a- f ( 2d is exempt) holding a functionalized substituent in the 4-position. Nine Glu analogues 2a- j are characterized pharmacologically at native 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), kainic acid (KA), and N-methyl- d-aspartic acid (NMDA) receptors in rat synaptosomes as well as in binding assays at cloned rat iGluR5-7 subtypes. A detailed in silico study address as to why 2h is a high-affinity ligand at iGluR5-7 ( K i = 3.81, 123, 57.3 nM, respectively), while 2e is only a high affinity ligand at iGluR5 ( K i = 42.8 nM). Furthermore, a small series of commercially available iGluR ligands are characterized in iGluR5-7 binding.
20
William S. Johnson, Lucius Werthemann, William R. Bartlett et al. · Journal of the American Chemical Society · 1970 · 629 citations
Natural Sciences, Chemistry, Natural Product Biosynthesis +8
P. Werner, Mark M. Voigt, Kari Keinänen et al. · Nature · 1991 · 470 citations